Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QL03AX17
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
||
|
NDF-RT |
N0000184997
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
||
|
WHO-ATC |
L03AX17
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
||
|
EMA ASSESSMENT REPORTS |
PROVENGE (WITHDRAWN: PROSTATIC, NEOPLASMS)
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
||
|
NCI_THESAURUS |
C129826
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
||
|
NCI_THESAURUS |
C1987
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m9955
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
PRIMARY | Merck Index | ||
|
8Q622VDR18
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
PRIMARY | |||
|
SIPULEUCEL-T
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
PRIMARY | |||
|
997261
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
PRIMARY | RxNorm | ||
|
8Q622VDR18
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
PRIMARY | |||
|
SUB32095
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
PRIMARY | |||
|
C1985
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
PRIMARY | |||
|
N0000184996
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
PRIMARY | Peripheral Blood Mononuclear Cells [Chemical/Ingredient] | ||
|
N0000184306
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
PRIMARY | Cell-mediated Immunity [PE] | ||
|
DB06688
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
PRIMARY | |||
|
RR-83
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
PRIMARY | |||
|
DTXSID50872279
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
PRIMARY | |||
|
917381-47-6
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
PRIMARY | |||
|
CHEMBL1237024
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
PRIMARY | |||
|
N0000184310
Created by
admin on Sat Dec 16 00:06:50 GMT 2023 , Edited by admin on Sat Dec 16 00:06:50 GMT 2023
|
PRIMARY | Cells, Cultured, Autologous [Chemical/Ingredient] |
ACTIVE MOIETY